Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study

Charlotte M. Verburgt, Katherine A. Dunn, Anthony Otley, Melvin B. Heyman, Sofia Verstraete, Withney Sunseri, Francisco Sylvester, Tim de Meij, Andre Comeau, Morgan Langille, Wouter J. de Jonge, Marc A. Benninga, Johan E. Van Limbergen

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Huella

Profundice en los temas de investigación de 'Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn's disease (CD): protocol of a pilot study'. En conjunto forman una huella única.

Medicine & Life Sciences